Cape Biologix has partnered with kit manufacturers in India for rapid scale-up of production earlier next year. Credit: Cryptographer / Shutterstock.

South Africa-based Cape Bio Pharms subsidiary Cape Biologix Technologies, Inno-3B, and PlantForm have signed a commercial agreement to increase the production of plant-based SARS-COV-2 antigens for a new Covid-19 antibody blood test.

According to the deal, Cape Biologix’s SARS-COV-2 antigens will be produced in plants grown by Inno-3B. PlantForm will extract, purify, and manufacture the antigens for use as the reagent in antibody test kits.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The three companies plan to provide fast, low-cost, and accurate plant-made proteins for Covid-19 monitoring and surveillance tools.

PlantForm CEO Dr Don Stewart said: “This collaboration meets a critical need for effective, low-cost and widespread serology testing to determine the prevalence of Covid-19 infection in different populations, its rate of spread and whether people who recover from it develop lasting immunity.”

Using technology initially developed by Cape Bio Pharms, Inno-3B, and PlantForm will produce the plant-based SARS-COV-2 antigens at their respective Canadian facilities in Saint-Pacôme, Quebec and Bolton in Ontario.

Cape Biologix CEO Belinda Shaw said: “It’s a simple finger-prick blood test that will detect whether a person has antibodies against the virus in their blood.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Continuous testing of communities is essential to provide a footprint of where the disease has been, as well as peace of mind to those who simply want to know – have I had it?”

Moreover, the test can deliver results within 15 minutes.

In addition, Cape Biologix has partnered with kit manufacturers in India for rapid scale-up of production earlier next year.

The company plans to supply proteins to test kit manufacturers across various international markets, including Brazil and Canada.